Recursion Pharmaceuticals
RXRX
#3963
Rank
C$3.10 B
Marketcap
$7.72
Share price
-0.89%
Change (1 day)
-26.56%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2024 (TTM): -C$0.65 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are C$58.48 Million. a decrease over its 2023 earnings that were of -C$0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.65 Billion39.51%
2023 -C$0.46 Billion38.68%
2022 -C$0.34 Billion30.46%
2021 -C$0.26 Billion114.28%
2020 -C$0.12 Billion